Tags: Addictionhealthaddiction | drug development | opioids | Pharmaceuticals | public health | STAT Breakthrough Summitart historydrug addiction
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA | ||
| 2 | Kristen Monaco MedPage Today | ||
| 3 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - about 1 month ago A tough week for MDMA-assisted psychotherapy - about 1 month ago FDA rejects MDMA as a psychedelic treatment for PTSD - about 1 month ago | |
| 4 | Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania | The FDA Just Rejected a Bid for MDMA to Treat PTSD - about 1 month ago | |
| 5 | Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York | MDMA therapy didn’t get FDA approval. Now what? - about 1 month ago | |
| 6 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | Neuro drugs are still faltering, despite rising investment - about 2 months ago | |
| 7 | Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. | ||
| 8 | Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. | ||
| 9 | Sarah Rose Sharp Hyperallergic Artist. Writer. Ultra freelance. Detroit, Michigan | The Art History of Addiction and Recovery - 3 months ago | |
| 10 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey |